Authors
Latest:
iRARC adoption is slow but persistent in bladder cancer"Over the past 10 to 15 years, tremendous efforts have gone into robotic surgical innovation to improve perioperative morbidity for patients with bladder cancer undergoing RC," write Andrew M. Wood, MD, and Nima Almassi, MD.
Latest:
Going “retro”: A perspective on robotic retroperitoneal renal surgeryImprovements in technology have renewed interest in the technique.
Latest:
Strategies to mitigate impact of intravenous ICM shortage"The global shortage of ICM has necessitated rapid adaptation of workflows and clinical pathways, which are particularly important for practicing urologists who are evaluating patients for hematuria," write Yair Lotan, MD, and colleagues.
Latest:
Dr. Xu discusses treatment selection across therapy lines in renal cell carcinoma“Now in 2023, it’s really a question of how to apply these agents and which combinations to use in the first line,” said Vincent (Wenxin) Xu, MD.
Latest:
Asked by a Resident: Dr. Efe Chantal Ghanney Simons interviews Dr. Mark S. Litwin"The most important thing I feel I've learned in my life so far is the value of human interaction and human connection," says Mark S. Litwin, MD, MPH.
Latest:
Future Directions in Imaging for Patients With Prostate CancerClosing out his review of imaging modalities in the setting of prostate cancer, Brian Helfand, MD, PhD, looks toward future evolutions in detection and treatment.
Latest:
Urologic implications of Lynch syndromeResearch indicates Lynch syndrome is associated with urothelial, prostate, and other urologic cancers.
Latest:
What is genetic discrimination, and why does it matter?Fear of discrimination has downstream effects on health care.
Latest:
Is now a good time to sell your medical practice to a private equity group?Industry expert provides in-depth advice.
Latest:
Strategies for dealing with difficult patientsIn this article, an expert addresses the most common issues that come up with patients that may make them harder to deal with and solutions that may help a provider.
Latest:
Management of hormone-naïve oligometastatic prostate cancerGrowing evidence supports the existence of an intermediate metastatic disease state.
Latest:
Drug interactions to monitor when prescribing erectile dysfunction medicationsMany of the medications used in the treatment of ED have interactions with other medications, so it is crucial to carefully examine patient profiles to optimize therapy and ensure safety.
Latest:
Michigan Institute of Urology (MIU) joins Solaris Health, nation's largest urological services providerMIU seizes innovation opportunities presented by dynamic national urology platform caring for nearly one-half million patients.
Latest:
The safety and oncologic benefits of transperineal vs transrectal MRI-guided prostate biopsy"These studies, taken together, offer important insight into the direction we should be heading in prostate cancer diagnosis: toward a targeted-only TP biopsy," write Tarik Benidir, MD, and Zeyad Schwen, MD.
Latest:
Urologic implications of Lynch syndromeResearch indicates Lynch syndrome is associated with urothelial, prostate, and other urologic cancers.
Latest:
Improving immune responses in prostate cancerMen with high-risk prostate cancer who received immunotherapy treatment with enoblituzumab in the weeks leading up to surgery had favorable rates of disease remission and tumor downgrading after surgery.
Latest:
Encouraging antitumor activity seen with neoadjuvant enfortumab vedotin in patients with cisplatin-ineligible MIBC“This first disclosure of data supports the ongoing phase 2 and 3 programs evaluating enfor-tumab vedotin alone or in combination with pembrolizumab in MIBC,” said Daniel P. Petrylak, MD.
Latest:
Update offers clues to optimal olaparib use in prostate cancerThe latest findings for the PARP inhibitor in prostate cancer come from an analysis of the pivotal phase 3 PROfound trial presented during the 2021 AUA Annual Meeting.
Latest:
Coaching program aims to alleviate female physician burnoutCofounders Adrienne Mann, MD, and Tyra Fainstad, MD, discuss Better Together, a professional, structured coaching program designed to address the burnout experienced by women in medicine.
Latest:
Get eTOC alerts from UrogynecologySubscribe to get new issue email alerts for Urogynecology that include the table of contents for the publication.
Latest:
Tumor mutation burden may predict outcomes from ADC in urothelial carcinomaThe ORR for patients was 47%. Of note, ORRs were higher in patients with specific alterations compared with wild type including ERBB2 (67% vs. 44%, respectively; P = .05) and TSC1 (68% vs. 25%; P = .04).
Latest:
Diversity in Urology: Progress made, but there is more work to be doneKelvin Moses, MD, PhD, interviews Tracy M. Downs, MD, about progress and remaining challenges regarding diversity, equity, and inclusion in the field of urology.
Latest:
Everything you need to know about medical coding and billing auditsThrough medical claims audits, the practice can help protected itself against fraudulent billing activity and claims.
Latest:
Tips for physicians to improve work-life balanceOverworking has become the norm, but that doesn’t mean it should be.
Latest:
Case report details spontaneous bladder rupture caused by herpes zoster–associated urinary retentionAlthough cases of acute urinary retention and defecation caused by herpes zoster in the sacral area have been reported, no clinical cases about spontaneous bladder rupture have been previously published, according to the authors.
Latest:
Molecular diagnostic practice in prostate and bladder cancers"Liquid biopsy analysis provides a noninvasive and facile tool for early detection, diagnosis, and recurrence surveillance of urological cancer," writes Jim Lu, MD, PhD.
Latest:
Strategies to mitigate impact of intravenous ICM shortage"The global shortage of ICM has necessitated rapid adaptation of workflows and clinical pathways, which are particularly important for practicing urologists who are evaluating patients for hematuria," write Yair Lotan, MD, and colleagues.
Latest:
Money Matters: Informing your perspective on the bear marketNo matter what your age or risk tolerance, investing is a lot easier and likely more successful if your perspective is informed by market history.
Latest:
Expert explains challenges of telehealthAlthough much of the discourse around telehealth rightfully focuses on its benefits, the potential drawbacks and limitations are often glossed over, particularly around provider burden.
